3-Hour Virtual Seminar - Assay Validation According to CLSI Guidelines

Monday, December 10, 2018   |   09:00 AM PST | 12:00 PM EST   |   Duration: 3 Hours      


One Dial-in One Attendee

Price: US$290.00

Corporate Live

Any number of participants


Duration: 3 Hours  


Access recorded version,
only for one participant ?

Price: US$340.00

Corporate Recorded

Access recorded version,
Any number of participants ?

Price: US$540.00

The seminar will use real life examples to demonstrate how to overcome some of the practical challenges when guidelines can not be exactly followed.
Dr. Shuguang Huang   Product Id : 502200
  Instructor : Dr. Shuguang Huang

  More Trainings by this Expert


Bioassay development and validation is very critical in pre-clinical drug discovery, clinical biomarker and translational research, diagnostic product (including companion diagnostic) development. In this presentation, overview if given for the terminologies, the scientific principles, and the regulatory guidelines that are related to assay validation.

Then each of the assay performance characteristics (specificity, sensitivity, accuracy, precision, linearity, stability, reportable range, reference range) will be explained in terms of experimental design and statistical analysis.

Most assay validations are a compromise between scientific principles, regulatory requirements, and limited resources in reality. The webinar will use real life examples to demonstrate how to overcome some of the practical challenges when guidelines can not be exactly followed

Why should you Attend: Though the CLSI guidelines provide much more actionable details than other guidelines (e.g. by FDA, USP), the understanding and adoption of the guidelines remains a challenge for the broad users. Plus, due to reality restraints, oftentimes the study design and/or the statistical analysis suggested by the guideline cannot be exactly followed.

In this webinar, major CLSI EP guidelines will be introduced. The focuses are (1) interpreting the procedure for each guideline, (2) intuitive explanation of the statistical methodologies, (3) using real-life examples to illustrate the use of the guidelines, and (4) discussing some solutions when facing challenges in implementing the guidelines.

Areas Covered in the Session:

  • Overview of Biomarker Development
  • CLSI Assay Validation Guidelines
  • Sensitivity (EP17)
  • Accuracy (EP9)
  • Precision (EP5)
  • Specificity (EP7)
  • Matrix effect (EP14)
  • Statistical Process Control (SPC)

Who Will Benefit:
  • Preclinical R&D Scientists
  • Clinical Labs
  • Translational Research
  • Diagnostic Labs
  • Lab CRO
  • CMC
  • Quality Control

Speaker Profile
Dr. Shuguang Huang has 20 years of experience working in pharmaceutical and diagnostic companies. He had assumed technical and management positions at Eli Lilly, Wyeth, Pfizer, and Precision Therapeutics, a cancer diagnostic company. In 2014, he co-founded and assumed the Chief Scientific Officer position for the statistics consulting company Stat4ward LLC.

His expertise includes (i) In-depth real-life expertise in assay development and validation. (ii) biomarker development and exploratory analysis. (iii) CMC and statistical process control.

Dr. Huang is actively involved in guideline development committees of Clinical Laboratory Standard Institute (CLSI) and he is a committee member of American Association of Pharmaceutical Scientists (AAPS) Flow cytometry Action Programming Committee.

Your Recently Viewed Webinars

Payment Methods

Contact Us

NetZealous LLC,
161 Mission Falls Lane, Suite 216,
Fremont, CA 94539, USA.


  Refund Policy